INDEMNITY AGREEMENTIndemnification Agreement • March 30th, 2023 • Fresh Tracks Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (“Agreement”) is made effective retroactive as of [insert date person became a director/officer/employee/agent of the Company for which indemnification will be provided], by and between Fresh Tracks Therapeutics, Inc., a Delaware corporation (the “Company”), and ____________, a ________ resident, with a domicile address of _________________ (“Indemnitee”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2023 • Fresh Tracks Therapeutics, Inc. • Biological products, (no disgnostic substances) • Colorado
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is made as of February 21, 2023 (the “Effective Date”) by and between FRESH TRACKS THERAPEUTICS, INC., f/k/a Brickell Biotech, Inc., the parent of Brickell Sub (“Brickell Parent”) and BRICKELL SUBSIDIARY, INC., d/b/a Brickell Biotech, Inc. (“Brickell Sub”), both being Delaware companies with a principal business address located at 5777 Central Avenue, Suite 102, Boulder, CO 80301 (Brickell Sub and, together with Brickell Parent and any predecessors of Brickell Sub or Brickell Parent, collectively referred to herein as the “Company”), and David R. McAvoy, an Indiana resident, with an address of [***] (the “Executive”).
FIFTH AMENDMENT TO LEASELease • March 30th, 2023 • Fresh Tracks Therapeutics, Inc. • Biological products, (no disgnostic substances)
THIS FIFTH AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 29th day of December, 2022, by and between BRE-BMR FLATIRON VII LLC, a Delaware limited liability company (“Landlord,” as successor-in-interest to GPIF 5777 Flatiron LLC and BMC Properties, LLC), and FRESH TRACKS THERAPEUTICS, INC., a Delaware corporation (“Tenant,” formerly known as Brickell Biotech, Inc.).
